When Is a Carcinogen Really a Carcinogen?

Few headlines generate more patient anxiety than “X classified as possible carcinogen.” In recent years, aspartame, red meat, cell phones, and aloe vera have all received some form of carcinogen designation—triggering patient questions, social media panic, and genuine confusion in the oncology clinic.

For pharmacists fielding those questions, the answer is rarely simple, but it is explainable. Understanding how carcinogens are classified and what those classifications actually mean at real-world exposures is increasingly essential clinical literacy.

What Does It Actually Mean When Something Is Called a Carcinogen?

The term “carcinogen” describes a substance capable of causing cancer, but that definition alone tells almost nothing about actual risk. The distinction that matters is between hazard and risk. The International Agency for Research on Cancer (IARC) classifications focus on the hazard linked to an agent—meaning whether a substance is capable of causing cancer—but this does not take risk into account, which is the probability of causing cancer given a specific level of exposure.¹

A substance can technically be capable of causing cancer at extremely high doses while posing effectively zero risk at the doses humans actually encounter. Most public-facing carcinogen headlines report the hazard without the risk, which is where the confusion begins.

How Does IARC Classify Carcinogens, and What Do the Groups Mean?

The IARC Monographs are systematic evaluations of the strength of evidence that an agent can cause cancer in humans, classified across four groups: Group 1 (carcinogenic to humans), Group 2A (probably carcinogenic to humans), Group 2B (possibly carcinogenic to humans), and Group 3 (not classifiable as to carcinogenicity in humans).²

The critical point—and the one most frequently lost in media coverage—is that substances being in the same group tells us the evidence for their carcinogenicity is comparable but tells us nothing about their relative risks.³ Alcohol and processed meat are both Group 1 carcinogens. Smoking causes approximately 19% of all cancers, and processed meat and red meat combined are thought to account for roughly 3%. Yet, they share the same classification tier.³

What Is Group 2B, and Why Does It Matter for Patient Counseling?

Group 2B is used when there is limited evidence of carcinogenicity in humans and less than sufficient evidence in experimental animals, or when there is insufficient evidence in humans but sufficient evidence in animals.⁴

The word “possibly” in Group 2B is doing real work—it signals genuine scientific uncertainty, not a finding of probable harm. Group 2B contains hundreds of substances, including aloe vera extract, pickled vegetables, talc-based body powder, and coffee (which was classified 2B until 2016, when it was downgraded to Group 3 after further review). The classification reflects the state of the evidence, not the magnitude of the threat.⁴

What Happened With Aspartame, and What Should Pharmacists Tell Patients?

Aspartame is the most instructive example of hazard-risk confusion. In July 2023, IARC classified aspartame as possibly carcinogenic to humans (Group 2B) based on limited evidence for hepatocellular carcinoma in humans, while simultaneously Joint Food and Agriculture Organization/WHO Expert Committee on Food Additives (JECFA) reaffirmed the acceptable daily intake of 40 mg/kg body weight.⁵

The same announcement, from the same WHO apparatus, said 2 different things: IARC identified a possible hazard; JECFA found the existing intake limit remained protective. JECFA found insufficient evidence linking aspartame to the risk of cancer or other diseases at usual consumption levels.⁶ The FDA went further, stating that aspartame being labeled possibly carcinogenic does not mean it is actually linked to cancer and that it disagreed with IARC's conclusion, identifying significant shortcomings in the studies on which IARC relied.⁷

The practical takeaway for patient counseling: An adult weighing 70 kg would need to consume 40 mg/kg/day—approximately 2800 mg—before reaching JECFA's acceptable daily intake (ADI) threshold. A standard diet soda contains roughly 180 mg of aspartame. A patient would need to consume more than 15 cans per day, every day, to approach the ADI, let alone the doses used in the animal studies that partially informed the 2B classification.

Are There Carcinogens Where the Risk Is Meaningful at Real-World Exposures?

Yes. Group 1 carcinogens include substances for which there is sufficient evidence of carcinogenicity in humans,² and several operate at doses patients actually encounter. Tobacco smoke, alcohol, UV radiation, radon, processed meat, and certain chemotherapy agents, including alkylating agents and topoisomerase II inhibitors, are all Group 1.

Occupational exposures—asbestos, benzene, formaldehyde, and certain wood dusts—represent Group 1 risks that are meaningful at real cumulative exposure levels. For oncology patients already on treatment, the secondary malignancy risk from some therapeutic agents is a genuine clinical consideration, not a theoretical hazard. The classification tier alone does not tell you which category a substance falls into that requires understanding the dose, duration, and route of exposure.²

How Should Pharmacists Use This Framework When Patients Ask?

Three questions cut through most carcinogen anxiety efficiently:

1. What group is the substance in, and what does that actually mean?
2. At what dose did the evidence for harm emerge, and how does that compare to real-world exposure?
3. Is there a risk-based assessment—from JECFA, the FDA, the US Environmental Protection Agency, or equivalent bodies—that evaluates actual exposure, not just hazard identification?

When patients arrive worried about a headline, they are usually responding to the hazard classification without the risk context. Pharmacists who can translate that distinction are providing one of the most genuinely useful forms of health literacy support available in any clinical encounter.

REFERENCES

1. International Agency for Research on Cancer. IARC Monographs on the Identification of Carcinogenic Hazards to Humans: list of classifications. Updated July 23, 2026. Accessed August 12, 2026. https://monographs.iarc.who.int/list-of-classifications

2. American Cancer Society Cancer Atlas. Human carcinogens. ©2025 American Cancer Society. Accessed August 12, 2026. https://canceratlas.cancer.org/risk-factors/human-carcinogens/

3. Compound Interest. What do the IARC's carcinogen classifications actually mean? July 14, 2023. Accessed August 12, 2026. https://www.compoundchem.com/2023/07/14/carcinogens/

4. Wikipedia. IARC group 2B. Updated February 15, 2026. Accessed August 12, 2026. https://en.wikipedia.org/wiki/IARC_group_2B

5. World Health Organization. Aspartame hazard and risk assessment results released. July 14, 2023. Accessed August 12, 2026. https://www.who.int/news/item/14-07-2023-aspartame-hazard-and-risk-assessment-results-released

6. World Cancer Research Fund. Statement on aspartame. July 14, 2023. Accessed August 12, 2026. https://www.wcrf.org/about-us/news-and-blogs/world-cancer-research-funds-statement-on-aspartame/

7. US Food and Drug Administration. Aspartame and other sweeteners in food. Updated February 27, 2025. Accessed August 12, 2026. https://www.fda.gov/food/food-additives-petitions/aspartame-and-other-sweeteners-food